17
Views
4
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

Prevalence of Integrons, blaCTX-M and blaTEM Resistance Markers among ESBL-Producing Uropathogenic Escherichia coli Isolates: First Report of Genomic blaCTX-M from India

Pages 131-134 | Published online: 18 Jul 2013
 

Abstract

Integrons have been observed to be frequently associated with uropathogenic bacteria. This study aimed at 1) determining the prevalence of class 1 integrons among eSbl-producing uropathogenic Escherichia coli, and 2) analyzing resistance genes associated with different phylogenetic groups of the integron-positive isolates with special reference to bla CTX-M and blatem. Twenty-three ESBL-producing E. coli were studied. Enterobacterial repetitive intergenic consensus-PCR (ERIC-PCR) displayed 14 major patterns. Pulse field Gel electrophoresis-typing of 8 randomly selected integron-positive strains ruled out any correlation between genotype and antibiotype. Genomic DNA from 14 strains was PCR-positive for class 1 integronsbla CTX-M-15 and bla TEM-1-like genes. Integron-sequencing revealed “aadA5-dfrA17-dfrA7” as the most prevalent gene cassette. Our findings unveil the increasing role of the bla-CTX-M genes in antibiotic resistance and emphasize on the significance of appropriate empirical treatment for Urinary tract infections. Moreover, this is the first study which reports bla CTX-M located on genomic DNA of bacteria from india.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.